\-\ Texto\\:\\ \ \(0\)\
\-\ diffuse\\ ttp\\,\\ soft\\,\\ non\\-distended\\,\\ \\+bs\\,\\ no\\ hsm\\,\\ no\\ rebound\\ tenderness\\.\ \(0\)\
\-\ ct\\ demonstrates\\ homogeneous\\ density\\ of\\ thickened\\ bowel\\ wall\\ with\\ intestinal\\ lumen\\ surrounded\\ by\\ edematous\\ mucosa\\.\\ \\ the\\ distal\\ jejunum\\ and\\ terminal\\ ileum\\ were\\ involve\\.\\ \\ intervening\\ segments\\ of\\ bowel\\ were\\ unremarkable\\.\ \(0\)\
\-\ subsequent\\ colonoscopy\\ demonstrated\\ nodularity\\ within\\ the\\ terminal\\ ileum\\.\ \(0\)\
\-\ small\\ bowel\\ follow\\ through\\ revealed\\ delayed\\ transit\\ time\\ with\\ persistent\\ narrowing\\ and\\ thickening\\ of\\ the\\ distal\\ jejunum\\ and\\ terminal\\ ileum\\.\ \(0\)\
\-\ crohns\\ disease\ \(0\)\
\-\ thickened\\ small\\ bowel\\ \\ folds\\ are\\ nonspecific\\ and\\ can\\ be\\ seen\\ in\\ a\\ wide\\ variety\\ of\\ condtions\\,\\ including\\ \\:\\ inflammatory\\ bowel\\ dieseae\\,\\ other\\ inflammatory\\ conditions\\,\\ ischemia\\,\\ hemorrhage\\,infection\\ \\(tb\\,\\ celiac\\)\\.\\ neoplasm\\ \\(lymphoma\\,\\ carcniod\\,\\ adenocarcinoma\\)\\ and\\ amyloidosis\\.\ \(0\)\
\-\ decreased\\ small\\ bowel\\ transit\\ time\\ is\\ possible\\ in\\:\\ inflammatory\\ bowel\\ dieseae\\,\\ hypothyroidism\\,\\ diabetes\\,\\ scleroderma\\,\\ opiate\\ use\\ or\\ celiac\\ disease\\.\ \(0\)\
\-\ 19\\ year\\-old\\ male\\ with\\ epigastric\\ abdominal\\ pain\\ and\\ hematochezia\\.\ \(1\)\
\-\ crohns\\ disease\\ is\\ an\\ idiopathic\\ inflammatory\\ process\\ which\\ can\\ involve\\ any\\ part\\ of\\ the\\ gi\\ tract\\ from\\ the\\ esophagus\\ to\\ rectum\\ \\(small\\ bowel\\-80\\%\\)\\.\\ \\ this\\ patient\\'s\\ findings\\ are\\ limited\\ to\\ the\\ distal\\ jejunum\\ and\\ terminal\\ ileum\\.\\ \\ these\\ findings\\ constitue\\ \\"skip\\ lesions\\"\\,\\ or\\ discontinous\\ involvement\\ of\\ bowel\\ segments\\,\\ with\\ normal\\ intervening\\ bowel\\.\ \(0\)\
\-\ crohns\\ can\\ be\\ categorized\\ into\\ 3\\ phases\\:\\ early\\,\\ advanced\\ and\\ stenotic\\.\\ \\ this\\ patient\\'s\\ presentation\\ is\\ most\\ consistent\\ with\\ the\\ early\\ phase\\ which\\ includes\\ nodular\\ enlargement\\ of\\ lymphoid\\ follices\\ with\\ obstructive\\ lyphedema\\ fist\\ arising\\ in\\ the\\ t\\.i\\.\\.\\ \\ later\\,\\ \\"advanced\\"\\ findings\\ may\\ include\\ \\ coboblestoning\\ and\\ lumenal\\ narrowing\\.\\ \\ the\\ final\\ or\\ \\"stenotic\\ phase\\"\\ involve\\ strictures\\ with\\ dilated\\ proximal\\ loops\\.\ \(0\)\
\-\ crohns\\ disease\\ can\\ exhibit\\ many\\ extraintestinal\\ manifestations\\ including\\ hepatobiliary\\,\\ gu\\,\\ msk\\ findings\\.\\ \\ this\\ young\\ patient\\ did\\ not\\ demonstrate\\ any\\ of\\ these\\ at\\ this\\ point\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bowel\\:\\ 0\\.35646714914979216\ \(0\)\
\-\ crohns\\:\\ 0\\.2889188780498762\ \(0\)\
\-\ terminal\\:\\ 0\\.22841665214266146\ \(0\)\
\-\ ileum\\:\\ 0\\.22484078923825043\ \(0\)\
\-\ jejunum\\:\\ 0\\.1977997797974448\ \(0\)\
\-\ dieseae\\:\\ 0\\.17765902617214385\ \(0\)\
\-\ inflammatory\\:\\ 0\\.15023785260646388\ \(0\)\
\-\ involve\\:\\ 0\\.14664144875412952\ \(0\)\
\-\ intervening\\:\\ 0\\.14631558342236323\ \(0\)\
\-\ transit\\:\\ 0\\.13486856981710962\ \(0\)\
\-\ stenotic\\:\\ 0\\.12847102671422855\ \(0\)\
\-\ celiac\\:\\ 0\\.12083609489189556\ \(0\)\
\-\ can\\:\\ 0\\.11659429309218343\ \(0\)\
\-\ small\\:\\ 0\\.11460917295235691\ \(0\)\
\-\ segments\\:\\ 0\\.1127650899175424\ \(0\)\
\-\ findings\\:\\ 0\\.10965593405242068\ \(0\)\
\-\ advanced\\:\\ 0\\.10441049661662019\ \(0\)\
\-\ and\\:\\ 0\\.10330037119147677\ \(0\)\
\-\ the\\:\\ 0\\.09975024604535532\ \(0\)\
\-\ distal\\:\\ 0\\.09682012874282303\ \(0\)\
\-\ phase\\:\\ 0\\.09506013793590226\ \(0\)\
\-\ thickened\\:\\ 0\\.09370717904063315\ \(0\)\
\-\ disease\\:\\ 0\\.0932642851212909\ \(0\)\
\-\ condtions\\:\\ 0\\.08882951308607193\ \(0\)\
\-\ carcniod\\:\\ 0\\.08882951308607193\ \(0\)\
\-\ constitue\\:\\ 0\\.08882951308607193\ \(0\)\
\-\ discontinous\\:\\ 0\\.08882951308607193\ \(0\)\
\-\ follices\\:\\ 0\\.08882951308607193\ \(0\)\
\-\ lyphedema\\:\\ 0\\.08882951308607193\ \(0\)\
\-\ coboblestoning\\:\\ 0\\.08882951308607193\ \(0\)\
\-\ of\\:\\ 0\\.08696023074740629\ \(0\)\
\-\ narrowing\\:\\ 0\\.08611822419186549\ \(0\)\
\-\ extraintestinal\\:\\ 0\\.08208007006524894\ \(0\)\
\-\ early\\:\\ 0\\.08007802645341948\ \(0\)\
\-\ opiate\\:\\ 0\\.0799072347320046\ \(0\)\
\-\ lumenal\\:\\ 0\\.0799072347320046\ \(0\)\
\-\ including\\:\\ 0\\.07950237540242072\ \(0\)\
\-\ hepatobiliary\\:\\ 0\\.07663087402124016\ \(0\)\
\-\ this\\:\\ 0\\.0763458792953529\ \(0\)\
\-\ with\\:\\ 0\\.07613566578148682\ \(0\)\
\-\ skip\\:\\ 0\\.07533062704442596\ \(0\)\
\-\ fist\\:\\ 0\\.07533062704442596\ \(0\)\
\-\ msk\\:\\ 0\\.07222971951246905\ \(0\)\
\-\ any\\:\\ 0\\.0717960325877377\ \(0\)\
\-\ hsm\\:\\ 0\\.07060304907731134\ \(0\)\
\-\ categorized\\:\\ 0\\.07060304907731134\ \(0\)\
\-\ hematochezia\\:\\ 0\\.06799085856014452\ \(0\)\
\-\ lymphoid\\:\\ 0\\.06799085856014452\ \(0\)\
\-\ time\\:\\ 0\\.06584656042178781\ \(0\)\
\-\ exhibit\\:\\ 0\\.06423551335711428\ \(0\)\
\-\ phases\\:\\ 0\\.06385360605648835\ \(0\)\
\-\ strictures\\:\\ 0\\.06385360605648835\ \(0\)\
\-\ gu\\:\\ 0\\.06385360605648835\ \(0\)\
\-\ these\\:\\ 0\\.06273318756476536\ \(0\)\
\-\ scleroderma\\:\\ 0\\.062140890395967235\ \(0\)\
\-\ nodularity\\:\\ 0\\.06153210542371049\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.06124141553932153\ \(0\)\
\-\ folds\\:\\ 0\\.05990543498855278\ \(0\)\
\-\ edematous\\:\\ 0\\.05965890566953563\ \(0\)\
\-\ variety\\:\\ 0\\.05873083347082307\ \(0\)\
\-\ or\\:\\ 0\\.057969979681147074\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.05788356993484441\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.05788356993484441\ \(0\)\
\-\ were\\:\\ 0\\.0572643077111484\ \(0\)\
\-\ surrounded\\:\\ 0\\.057104163035665366\ \(0\)\
\-\ epigastric\\:\\ 0\\.057104163035665366\ \(0\)\
\-\ manifestations\\:\\ 0\\.0569186833710141\ \(0\)\
\-\ ttp\\:\\ 0\\.056557998137578724\ \(0\)\
\-\ intestinal\\:\\ 0\\.05621019730956261\ \(0\)\
\-\ rectum\\:\\ 0\\.05604084716321743\ \(0\)\
\-\ final\\:\\ 0\\.05449197251849854\ \(0\)\
\-\ patient\\:\\ 0\\.054198589572231726\ \(0\)\
\-\ wide\\:\\ 0\\.05380108793784346\ \(0\)\
\-\ mucosa\\:\\ 0\\.05353789926835571\ \(0\)\
\-\ rebound\\:\\ 0\\.052909462648712643\ \(0\)\
\-\ nonspecific\\:\\ 0\\.052205248308310095\ \(0\)\
\-\ obstructive\\:\\ 0\\.05165496699165658\ \(0\)\
\-\ conditions\\:\\ 0\\.0507366273154683\ \(0\)\
\-\ diabetes\\:\\ 0\\.0507366273154683\ \(0\)\
\-\ which\\:\\ 0\\.05051427757000128\ \(0\)\
\-\ loops\\:\\ 0\\.050448801789968925\ \(0\)\
\-\ part\\:\\ 0\\.04963310193794821\ \(0\)\
\-\ lumen\\:\\ 0\\.04946075428873962\ \(0\)\
\-\ tb\\:\\ 0\\.04946075428873962\ \(0\)\
\-\ homogeneous\\:\\ 0\\.04904277647448976\ \(0\)\
\-\ ischemia\\:\\ 0\\.04810726831667211\ \(0\)\
\-\ idiopathic\\:\\ 0\\.04698517784682684\ \(0\)\
\-\ gi\\:\\ 0\\.046659482335852195\ \(0\)\
\-\ tract\\:\\ 0\\.046532194405991295\ \(0\)\
\-\ point\\:\\ 0\\.04591957807898321\ \(0\)\
\-\ young\\:\\ 0\\.045801547688696084\ \(0\)\
\-\ esophagus\\:\\ 0\\.045743064702235194\ \(0\)\
\-\ is\\:\\ 0\\.04563462308599741\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.04539935650345865\ \(0\)\
\-\ be\\:\\ 0\\.04506526188915173\ \(0\)\
\-\ limited\\:\\ 0\\.04433409994580749\ \(0\)\
\-\ nodular\\:\\ 0\\.044233713613662455\ \(0\)\
\-\ arising\\:\\ 0\\.04413435164971393\ \(0\)\
\-\ 19\\:\\ 0\\.04398718429464531\ \(0\)\
\-\ many\\:\\ 0\\.043794358429739985\ \(0\)\
\-\ delayed\\:\\ 0\\.04346583707459318\ \(0\)\
\-\ includes\\:\\ 0\\.043192808310312476\ \(0\)\
\-\ persistent\\:\\ 0\\.04279710378743498\ \(0\)\
\-\ enlargement\\:\\ 0\\.04258402333805573\ \(0\)\
\-\ use\\:\\ 0\\.04250007981840525\ \(0\)\
\-\ are\\:\\ 0\\.04215406102692493\ \(0\)\
\-\ subsequent\\:\\ 0\\.042050896333900814\ \(0\)\
\-\ process\\:\\ 0\\.04165978400220505\ \(0\)\
\-\ in\\:\\ 0\\.04145383076461525\ \(0\)\
\-\ involvement\\:\\ 0\\.04020267065849646\ \(0\)\
\-\ did\\:\\ 0\\.03984618736180441\ \(0\)\
\-\ dilated\\:\\ 0\\.039782751385168305\ \(0\)\
\-\ later\\:\\ 0\\.03975118770121036\ \(0\)\
\-\ presentation\\:\\ 0\\.03823666668974741\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0379182496110045\ \(0\)\
\-\ thickening\\:\\ 0\\.0377885887341415\ \(0\)\
\-\ possible\\:\\ 0\\.03763524087237545\ \(0\)\
\-\ unremarkable\\:\\ 0\\.037237741273822324\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0371891756470884\ \(0\)\
\-\ density\\:\\ 0\\.036832454879192573\ \(0\)\
\-\ revealed\\:\\ 0\\.036420954720391537\ \(0\)\
\-\ no\\:\\ 0\\.03612559675565843\ \(0\)\
\-\ diffuse\\:\\ 0\\.034833968919488034\ \(0\)\
\-\ tenderness\\:\\ 0\\.034833968919488034\ \(0\)\
\-\ proximal\\:\\ 0\\.034701742414700094\ \(0\)\
\-\ decreased\\:\\ 0\\.0344060874305308\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03413683374186541\ \(0\)\
\-\ wall\\:\\ 0\\.0337890329138493\ \(0\)\
\-\ infection\\:\\ 0\\.0335527588753745\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0330808465611645\ \(0\)\
\-\ through\\:\\ 0\\.033064974694610595\ \(0\)\
\-\ include\\:\\ 0\\.03304912865698031\ \(0\)\
\-\ lesions\\:\\ 0\\.03190047046181267\ \(0\)\
\-\ abdominal\\:\\ 0\\.030379364249554678\ \(0\)\
\-\ consistent\\:\\ 0\\.030118101582738477\ \(0\)\
\-\ follow\\:\\ 0\\.029943903950058012\ \(0\)\
\-\ soft\\:\\ 0\\.02957129755971478\ \(0\)\
\-\ into\\:\\ 0\\.029527086868671004\ \(0\)\
\-\ most\\:\\ 0\\.028907614314645152\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02887661995009483\ \(0\)\
\-\ other\\:\\ 0\\.028845723928484668\ \(0\)\
\-\ may\\:\\ 0\\.027952299393877104\ \(0\)\
\-\ demonstrates\\:\\ 0\\.027905507434661813\ \(0\)\
\-\ to\\:\\ 0\\.02777258377623781\ \(0\)\
\-\ seen\\:\\ 0\\.02615042061451756\ \(0\)\
\-\ within\\:\\ 0\\.025582592367883097\ \(0\)\
\-\ male\\:\\ 0\\.02473103963850379\ \(0\)\
\-\ by\\:\\ 0\\.02358788495264037\ \(0\)\
\-\ normal\\:\\ 0\\.02267889765877011\ \(0\)\
\-\ from\\:\\ 0\\.02206035901405078\ \(0\)\
\-\ not\\:\\ 0\\.02192808316213239\ \(0\)\
\-\ an\\:\\ 0\\.021240452512326265\ \(0\)\
\-\ ct\\:\\ 0\\.021146732944054336\ \(0\)\
\-\ at\\:\\ 0\\.020980277814223694\ \(0\)\
\-\ pain\\:\\ 0\\.019876261257204653\ \(0\)\
